SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in CSTL — Castle Biosciences Inc
CIK 1232395
NEW YORK, NY
Position in CSTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,592,534
-$1,382,043 QoQ
Shares Held
268,535
+31.0% QoQ
Ownership
0.885%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in CSTL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $175,895,059 across 15 Diagnostics & Research names. CSTL ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
90,091 | $44,282,429 | |
| 2 | A |
Agilent Technologies, Inc.
|
257,387 | $29,336,970 | |
| 3 | DGX |
Quest Diagnostics Inc
|
114,758 | $22,490,272 | |
| 4 | RDNT |
RadNet, Inc.
|
381,502 | $21,322,146 | |
| 5 | DHR |
Danaher Corp /De/
|
105,157 | $19,937,767 | |
| 6 | TWST |
Twist Bioscience Corp
|
244,025 | $11,596,068 | |
| 7 | CSTL |
Castle Biosciences Inc
This page
|
268,535 | $6,592,534 | |
| 8 | LH |
Labcorp Holdings Inc.
|
20,338 | $5,426,381 |
All Filings in CSTL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,592,534 | 268,535 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,974,577 | 205,002 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,376,809 | 367,888 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,716,762 | 279,959 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,980,016 | 198,802 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,328,667 | 199,950 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,758,786 | 201,921 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||